Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.32 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.32 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | PGK1 | P00558 | 2/20 | 0.31 |
| ▸ | PGK2 | P07205 | 2/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2681260 | 0.78 | TSHR (0.55) | GAATSHRKCNA5KCNH2CYP2D6 | |
| SCHEMBL18762843 | 0.71 | OPRM1 (0.39) | GAAHPGD | |
| SCHEMBL10062682 | 0.70 | MEN1 (0.42) | GAAHPGDIRAK4CYP2D6 | |
| SCHEMBL522348 | 0.70 | IRAK4 (0.40) | GAATSHRIRAK4PGK1PGK2 | |
| SCHEMBL3631871 | 0.70 | TSHR (0.41) | GAAHPGDTSHRIRAK4KCNH2 | |
| SCHEMBL522830 | 0.68 | IRAK4 (0.40) | IRAK4KCNH2PGK1PGK2 | |
| SCHEMBL8926699 | 0.68 | HTR2A (0.48) | GAAHPGDTSHRKCNH2CYP2D6 | |
| SCHEMBL119104 | 0.68 | HTR2A (0.48) | GAAHPGDTSHRKCNH2CYP2D6 | |
| SCHEMBL171013 | 0.68 | HTR2A (0.48) | GAAHPGDTSHRKCNH2CYP2D6 | |
| SCHEMBL11071839 | 0.68 | GAA (0.31) | GAAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2415742-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND AND CATALYST THEREFOR | Sumitomo Chemical Company, Limited (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-20120029195-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND AND CATALYST THEREFOR | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029195-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND AND CATALYST THEREFOR | ADH1A, ADH1C, ADH5 | GAA 3855/4885HPGD 332/4885TSHR 2411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.